In what is being described as the first ever and most comprehensive
study of the effects of genetically modified foods on mammalian health,
researchers have linked organ damage with consumption of Monsanto’s GM
maize.

All three varieties of GM corn, Mon 810, Mon 863 and NK 603, were
approved for consumption by US, European and several other national
food safety authorities. Made public by European authorities in 2005,
Monsanto’s confidential raw data of its 2002 feeding trials on rats
that these researchers analyzed is the same data, ironically, that was
used to approve them in different parts of the world.

The Committee of Research and Information on Genetic Engineering
(CRIIGEN) and Universities of Caen and Rouen studied Monsanto’s 90-day
feeding trials data of insecticide producing Mon 810, Mon 863 and
Roundup® herbicide absorbing NK 603 varieties of GM maize.

The data “clearly underlines adverse impacts on kidneys and liver,
the dietary detoxifying organs, as well as different levels of damages
to heart, adrenal glands, spleen and haematopoietic system,” reported
Gilles-Eric Séralini, a molecular biologist at the University of Caen.

Although different levels of adverse impact on vital organs were
noticed between the three GMOs, the 2009 research shows specific
effects associated with consumption of each GMO, differentiated by sex
and dose.

Their December 2009 study appears in the

International Journal of Biological Sciences (IJBS). This latest study conforms with a 2007 analysis by CRIIGEN on Mon 863, published in

Environmental Contamination and Toxicology, using the same data.

Monsanto rejected
the 2007 conclusions, stating: “The analyses conducted by these authors
are not consistent with what has been traditionally accepted for use by
regulatory toxicologists for analysis of rat toxicology data.”¹